Latest Institutional Transactions on Lexaria Bioscience Corp (LEXXW)
This table provides information on the latest institutional transactions involving Lexaria Bioscience Corp (LEXXW) stock. The table includes the name of the institution, the type of operation (buy or sell), whether options were involved, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the transaction has occurred.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Heights Capital Management, Inc
San Francisco, CA |
BUY
|
- |
41.3KNew |
$37.1K - $82.5K
|
41.3K
$26.4K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
SELL
|
- |
-65.7K- 70.06% |
$59.1K - $131K
|
28.1K
$18K
|
|
|
Nov 14, 2024
Q3 2024
|
Clear Street LLC
|
BUY
|
- |
100+ 100.0% |
$90 - $200
|
200
$128
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
| Q4 2023 | |||||||
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-6.64K- 33.39% |
$796 - $5.18K
|
13.2K
$8.47K
|
|
|
Feb 14, 2024
Q4 2023
|
Cvi Holdings, LLC
Wilmington, DE |
SELL
|
- |
-349- 0.83% |
$41.9 - $272
|
41.7K
$26.7K
|
|
| Q3 2023 | |||||||
|
Nov 14, 2023
Q3 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-30.2K- 12.58% |
$4.84K - $9.37K
|
210K
$134K
|
|
| Q2 2022 | |||||||
|
Aug 12, 2022
Q2 2022
|
Empery Asset Management, LP
New York, NY |
SELL
|
- |
-4.47K- 3.42% |
$2.64K - $5.94K
|
126K
$80.8K
|
|
| Q3 2021 | |||||||
|
Nov 15, 2021
Q3 2021
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-362KClosed |
$746K - $1.13M
|
0
$0
|
|
| Q1 2021 | |||||||
|
May 17, 2021
Q1 2021
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
- |
79KNew |
$83.7K - $239K
|
79K
$50.5K
|
|